Organization
OMRF, Oklahoma City, OK
1 abstract
Abstract
BELIMUMAB (FULLY HUMAN MONOCLONAL ANTIBODY TO BLYS) REDUCED STEROID USE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS DURING 3 YEARS OF THERAPYOrg: SUNY Downstate, Brooklyn, NY, Cedars-Sinai UCLA, Los Angeles, CA, Univ of AL at Birmingham, Birmingham, AL, OK Center for Arthritis Therapy and Research, Tulsa, NSLIJHS, Lake Success, NY,